We are a VC fund focused on investing in early-stage companies in the healthcare sector.
Barcelona
Joined October 2019
- Tweets320
- Following148
- Followers632
- Likes349
Invivo Partners retweeted
🏥🚀 Vine a les jornades del #CampusClínicInnova 2024 on ponents destacats parlaran sobre innnovació en salut:
✔️ Disseny de sistemes de simulació en salut
✔️ Teràpies avançades
✔️ El futur de la medicina
✔️ IA en transformació digital
Inscriu-t'hi 👉 i.mtr.cool/tymggnnbgb
Invivo Partners retweeted
Cerramos la mañana hablando sobre el rol de las instituciones en empresas participadas con:
✅@AnaRodriguezC11 (consultora)
✅ @laurg87 (@InvivoPartners)
✅ Rafael Máñez (@Remabtx)
✅ @ypuiggros (@PwC_Spain)
Moderan Lluís Blanch (ITEMAS) y Ramon Maspons (@AQuAScat)
Invivo Partners retweeted
Telum Therapeutics appoints Dr. Subhendu Basu as CEO: bit.ly/3PtWOw9
He joins Telum to lead it into its next phase, focused on defining strategy, expanding the pipeline and driving corporate development.
#AntimicrobialResistance #InfectiousDiseases #MachineLearning
Invivo Partners retweeted
💡 Les teràpies avançades i emergents obren la porta al disseny de nous tractaments per a les malalties i lesions.
En #BIOEuropeSpring (18–20 de març, 📍Barcelona) un panell d'experts debatrà sobre com impulsar els #ATMPs.
Consulta l'agenda: biocat.cat/ca/actualitat/age…
Invivo Partners retweeted
Advanced therapies are the key for moving towards a more personalized medicine, but their implementation has a very high cost.
You want to know what the current challenges are and how they can be solved❓
Follow the discussion live:
👉bit.ly/InformeBioRegio2023-s…
Invivo Partners retweeted
“In regards of Advanced Therapies we need to arrive to more patients and at less cost. We have to be prepared for that!” said Lluis Pareras @InvivoPartners , roundtable Biocat Report presentation #informeBioRegio @biocat_en
Invivo Partners retweeted
🌟 Great news for #OneChain! We warmly welcome Dr. Stefanos Theoharis as our new CEO.
With his vast business experience and expertise in cell and gene therapy, we are ready to take our company into a new phase of growth! 👇
pcb.ub.edu/en/stefanos-theoh…
Invivo Partners retweeted
#VentureCapital: @InvivoPartners invierte en @EsoBiotec para revolucionar la terapia celular contra el cáncer con una avanzada plataforma de ingeniería in vivo webcapitalriesgo.com/invivo-…
Invivo Partners retweeted
. @InvivoPartners invierte en la biotecnológica belga EsoBiotec capital-riesgo.es/es/article…
Invivo Partners retweeted
The American Assoc for Physician Leadership will publish my upcoming book "Fast Forward Thinking: 40 Rules for Entrepreneurs & Investors in Science & Biotech". It will have many of my quick notes, some of which have never been published before. It'll be out before the year ends.
Invivo Partners retweeted
🤔 Curious about CAR-T therapy and how it's revolutionizing #cancer treatment?
🎬 Our latest video explains the process by which these therapies are developed and highlights our role in advancing them.
A must-watch for everyone! @CarrerasIJC @fcarreras youtu.be/tdHGEkqvBic
Invivo Partners retweeted
European Week Against Cancer is here and we've prepared something very special!
Have you ever wondered how CAR-T therapy works? 🤔 Check out our motion graphic video that breaks down the science behind these life-saving treatments! 🎬🩺🧪 #EWAC2023 youtu.be/tdHGEkqvBic
Invivo Partners retweeted
💥 The Fast Track Program to Barcelona – Catalonia concludes with success!
Our Fast Track Program for #AdvancedTherapy companies was filled with knowledge sharing, insightful discussions, and exceptional speakers that brought together 20 selected companies from around the world.
Invivo Partners retweeted
🆕 Nou èxit d’un fons català!
📰 @Arthexbiotech, una spin off de la @UV_EG, aconsegueix 42 milions d'euros per a un fàrmac contra la #distròfia miotònica tipus 1
👇 A @elEconomistaes
ow.ly/R6HU50Ofqgx
Invivo Partners retweeted
#VentureCapital: ARTHEx Biotech announces Closing of €42M Series B round led by @columbus_vp . EIC), Hadean, Sound Bioventures, @InvivoCapital , @AdBiopartners and @CDTI_innovacion also participated. webcapitalriesgo.com/arthex-…
Invivo Partners retweeted
PORTFOLIO NEWS/ Happy to announce ARTHEX raised €42M Series B to develop a new DM1 treatment. As their first investor, we're proud to support company creation & early-stage investments in tech transfer. Many unaddressed clinical needs remain—let's keep innovating for patients
Invivo Partners retweeted
Attention all female #entrepreneurs 👩💼
Showcase your #healthcare 🩺 company at the #EUeic WLP ePitching!
This opportunity is open to both current & former participants & includes pitching, coaching, and one-to-one meetings with investors. 🚀
👉 bit.ly/EICWLPhealthcare
Invivo Partners retweeted
👨💼@XavierFerras, Associate dean of the #EsadeEMBA was joined by Lluís Pareras, founder @InvivoCapital, and Josep Maria Martorell, Associate dir. @BSC_CNS, to debate how HPC technologies, like #AI, can revolutionise the future of sports' medicine, at @BarcaInnoHub.
Invivo Partners retweeted
🚀 Si ets una #startup del sector salut i cerques finançament, ja pots enviar la teva candidatura per participar en el 32è Fòrum d'Inversió Healthcare Barcelona
➡️ Biotecnologia
➡️ Medical Devices
➡️ Serveis sanitaris
➡️ TIC
⌛️ Data límit: 7 de febrer
comb.cat/ca/serveis/emprened…
Invivo Partners retweeted
Ready to revolutionise cancer care? 🩺
Join the #EUeic Investor Day and pitch your game-changing #innovations to 🔝 investors.
Your #SME could be part of the next big thing in cancer treatment and prevention.
Apply by 9 February 👉 bit.ly/EICInvestorDaycancert…
